- GlobeNewswire•14 hours ago
COLUMBIA, Md., March 27, 2017-- Osiris Therapeutics, Inc., a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced ...
- Capital Cube•7 days ago
Categories: Yahoo Finance Osiris Therapeutics, Inc. relative valuation is UNDERVALUED and it has a fundamental analysis score of 86. Our analysis is based on comparing Osiris Therapeutics, Inc. with the following peers – Vericel Corporation, Integra LifeSciences Holdings Corporation, Geron Corporation, Johnson & Johnson, Xtant Medical Holdings, Inc., CONMED Corporation, Nektar Therapeutics and Pluristem Therapeutics Inc. (VCEL-US, IART-US, ... Read more (Read more...)
- Accesswire•14 days ago
NEW YORK, NY / ACCESSWIRE / March 14, 2017 / The competition between Osiris Therapeutics and competitor PTC has ended with an unceremonious thud. Osiris has come to the end of its NASDAQ run today, after ...
OSIR : Summary for OSIRIS THERAPE INC COM STK USD0 - Yahoo Finance
Osiris Therapeutics, Inc. (OSIR)
NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
|Day's Range||3.87 - 4.00|
|52 Week Range||2.67 - 7.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||94.05|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|